Deinove

Latest news

27.01.2020

Enrolment of first patient in Phase II trial testing DNV3837 in Clostridioides difficile infections

The Phase II clinical trial aims to evaluate the efficacy, safety and pharmacokinetics of DNV3837...

22.01.2020

New industrial-scale production of Phyt-N-Resist® to supply the market

DEINOVE launches the production of a new batch of Phyt-N-Resist® to meet the needs of its...

More press releases

Antibiotic resistance, a global health challenge

The development of antibiotic resistance is, according to international organizations and governments, one of the major health challenges of the 21st century

More info

In the Medias

19.06.2019

DEINOVE among The Top 20 Industrial Biotechnology Companies in Europe

Europe’s industrial biotechnology sector is driving a massive change from petrochemical processes to more sustainable alternatives. Here...

14.06.2019

Formule Verte | Deinove et Avril avancent sur leur nouvelle gamme d’ingrédients

La société de biotechnologies industrielles Deinove et Avril, l’acteur industriel et financier des filières des huiles et des protéines,...

More press coverage

Disruptive innovation

Latest news

Antibiotic resistance, a global health challenge

In the Medias